Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes. - Kim C; Bu F; Blacketer C; Ostropolets A; Duarte-Salles T; Viernes B; Falconer T; Pistillo A; Li J; Yin C; Van Zandt M; Nagy P; et al. (Nature communications, 2026)